E. Gerlach
About
In The Last Decade
E. Gerlach
229 papers receiving 5.7k citations
Peers
Comparison fields: 5 of 140
- Molecular Biology 1.7k
- Cardiology and Cardiovascular Medicine 1.3k
- Pharmacology 1.2k
- Pathology and Forensic Medicine 1.1k
- Physiology 1.0k
Countries citing papers authored by E. Gerlach
This map shows the geographic impact of E. Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Gerlach more than expected).
Fields of papers citing papers by E. Gerlach
This network shows the impact of papers produced by E. Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Gerlach. The network helps show where E. Gerlach may publish in the future.
Co-authorship network of co-authors of E. Gerlach
This figure shows the co-authorship network connecting the top 25 collaborators of E. Gerlach. A scholar is included among the top collaborators of E. Gerlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Gerlach. E. Gerlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 9 | |
| 2 | 12 | |
| 3 | 27 | |
| 4 | 10 | |
| 5 | 5 | |
| 6 | 6 | |
| 7 | 16 | |
| 8 | [Are the radical scavenging properties of ACE inhibitors with sulfhydryl groups in therapeutically effective concentrations of quantitative significance?]. | 2 |
| 9 | 17 | |
| 10 | 78 | |
| 11 | 110 | |
| 12 | 25 | |
| 13 | 4 | |
| 14 | 26 | |
| 15 | 24 | |
| 16 | 13 | |
| 17 | 114 | |
| 18 | Alterations of myocardial adenine nucleotide metabolism. | 5 |
| 19 | Erythrocytes, thrombocytes, leukocytes. Recent advances in membrane and metabolic research : 2nd International Symposium, Vienna 1972 | 2 |
| 20 | In vitro Inhibition of Migration of Leukocytes by Old Tuberculin (OT) as an Indicator of Active Tuberculosis. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.